Outcomes Study: Identifying and Addressing Nonadherence Risk with a Technology-Supported Pharmacist-Led Risk Stratification Process at a Health-System Specialty Pharmacy

Members of our team had the opportunity to present a new poster abstract, "Identifying and Addressing Nonadherence Risk with a Technology-Supported Pharmacist-Led Risk Stratification Process at a Health-System Specialty Pharmacy", at the NASP 2025 Annual Meeting & Expo.

Authors:

Lily Duong, PharmD; Courtney Smith, PharmD; Abbas Dewji, PharmD; Joshua Bastian, MBA; Andrew Wash, PharmD; Casey Fitzpatrick, PharmD; James Steigerwalt, PharmD

Background:

• Health-system specialty pharmacy (HSSP) teams within specialty clinics are often responsible for providing care to high-volume patient populations.^1-3

• Leveraging technology platforms and utilizing risk stratification models can allow HSSP teams to focus their time on supporting rheumatoid arthritis (RA) patients at risk of nonadherence.^1-3

Objectives:

• To describe a technology-supported risk stratification model utilized by HSSP teams in providing targeted adherence support to patients with RA at risk of nonadherence.
  

Read about the team's findings by downloading the outcomes study below.

 ¹ Maguire J. Specialty pharmacy workflow operations: technological considerations overview. Specialty Pharmacy Times. October 10, 2012;3(5). https://www.pharmacytimes.com/view /specialty-pharmacy­-work-flow-operations-technological-considerations-overview 

² Kim J, Combs K, Downs J, Tillman F. Medication adherence: the elephant in the room. US Pharm. 2018;43(1)30-34.

³ Oshotse C, Zullig LL, Bosworth HB, Tu P, Lin C. Self-efficacy and adherence behaviors in rheumatoid arthritis patients. Prev Chronic Dis. 2018;15:e127. doi: 10.5888/pcdlS.180218